This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Jacob Rendell: Innovator in Pharmaceutical Chemistry
Introduction
Jacob Rendell is a notable inventor based in Beer Sheva, Israel. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds. With a total of 2 patents to his name, Rendell's work has the potential to impact the medical community positively.
Latest Patents
Rendell's latest patents focus on Nilotinib salts and crystalline forms thereof. These compounds have been meticulously prepared and characterized, showcasing his expertise in pharmaceutical formulations. The advancements in Nilotinib salts are crucial for enhancing the efficacy of treatments related to certain medical conditions.
Career Highlights
Jacob Rendell is currently employed at Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His role involves extensive research and development, where he applies his knowledge to create innovative solutions in drug formulation. His contributions to the company have been instrumental in advancing their product offerings.
Collaborations
Rendell collaborates with various professionals in his field, including his coworker Maytal Piran. Together, they work on projects that aim to push the boundaries of pharmaceutical research and development.
Conclusion
Jacob Rendell is a dedicated inventor whose work in pharmaceutical chemistry is paving the way for new treatments. His patents and collaborations reflect his commitment to innovation in the medical field.